Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.
The company possesses a narrow moat derived from cost-efficient manufacturing of technical-grade pesticides and long-standing relationships with multinational partners. While high average ROCE of 24% suggests competitive strength, the lack of proprietary molecules and exposure to generic pricing pressure from China limits the moat's width.
Earnings are primarily reinvested into capacity expansion, such as the ongoing construction of Unit-III in Dahej and R&D facilities. The company maintains an exceptionally conservative balance sheet with near-zero debt, though dividend payouts remain modest to prioritize growth.
The investment collapsed as the company's dependence on generic technical-grade pesticides met a structural glut in Chinese supply, permanently crushing margins. The massive capital expenditure for Unit-III in Dahej became a stranded asset, as the 37.6% decline in profits observed in 2024 proved to be a permanent reset rather than a cyclical dip. Meanwhile, the lack of proprietary intellectual property left the firm powerless against multinational partners who squeezed procurement prices, while the unresolved fire insurance claims and environmental penalties signaled a deterioration in operational discipline that the market finally priced in.
RichFakir rates Bharat Rasayan Ltd's business quality as mediocre — 62/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Bharat Rasayan Ltd is trading about 23% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Bharat Rasayan Ltd is: Not rated. A mediocre business at a fair price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Bharat Rasayan Ltd's fair value is about ₹1,208 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →